Fulcrum Announces Initiation of ReDUX4, a Phase 2b Clinical Trial of Losmapimod for FSHD
[…] announced it has initiated ReDUX4, a Phase 2b clinical trial of losmapimod in facioscapulohumeral muscular dystrophy ( FSHD). The clinical trial is designed to evaluate the efficacy and safety of losmapimod, an […]